We often say that tomorrow and accidents—no one knows which will come first. But for the Chinese population, one type of “accident” is growing at an alarming rate—stroke. According to Global Burden of Disease (GBD) 2021 data, China already has the highest stroke incidence rate in the world. There are approximately 3.4 million new stroke cases each year, accounting for 30% of the global total—on average, one person develops the condition every 10 seconds. Even more concerning, the lifetime risk of stroke for Chinese residents is as high as 40%, ranking first among 197 countries worldwide.
However, this is not the end point. A recent study published in Stroke paints an extremely grim picture of the future.
I. Numbers in Motion: From 4.35 Million to 9.59 Million
Researchers from Nanjing Medical University, Shandong University, and other institutions used GBD 2021 data to build a predictive model projecting stroke incidence and costs in China over the next 30 years (2022 to 2050).
The results are alarming. The study projects that the total number of new stroke cases in China will surge from 4.35 million in 2022 to 9.59 million in 2050—meaning that in less than three decades, the annual number of new stroke patients will more than double (an increase of approximately 120%).
This growth is not uniform across stroke types. Among the three major subtypes, ischemic stroke will become the dominant driver. By 2050, its annual incidence is projected to reach 7.89 million cases, 2.6 times the 2022 figure (2.96 million). In contrast, intracerebral hemorrhage—a subtype of hemorrhagic stroke—will see relatively slower growth (from 1.24 million to 1.59 million), while subarachnoid hemorrhage cases are expected to decline.
The driving forces behind these trends are the combined effects of population aging and divergent incidence trends across stroke subtypes. The incidence of ischemic stroke continues to rise, while subarachnoid hemorrhage has shown a long‑term downward trend due to improved hypertension control, declining smoking rates, and other factors.
II. A Heavy Burden: From USD 46.1 Billion to USD 91.2 Billion
Behind every new case lies a family’s struggle and a substantial financial toll.
The study projects that China’s total annual hospitalization costs for stroke will soar from USD 46.1 billion in 2022 to USD 91.2 billion in 2050—nearly doubling. If we broaden the perspective to include post‑discharge rehabilitation, nursing care, and socioeconomic losses due to disability (i.e., direct medical costs plus total societal costs), the figure becomes even more staggering:
Direct medical costs (including hospitalization and follow‑up care): projected to rise from USD 67.6 billion to USD 133.9 billion.
Total societal costs (including direct and indirect losses): projected to rise from USD 145.6 billion to USD 288.4 billion.
This enormous financial burden will increasingly fall on the elderly. The study clearly indicates that the fastest cost growth will occur in the population aged 65 years and older, particularly those aged 85 and above. By 2050, hospitalization costs for the 85+ age group will skyrocket from USD 6.2 billion in 2022 to USD 21.7 billion.
III. Why Us?
The grim future depicted by this projection stems from two core factors: demographic shifts and epidemiological transitions.
The wave of aging: Age is the single largest risk factor for stroke. As China’s society ages, even if age‑specific incidence rates remain unchanged, the absolute number of stroke cases will inevitably rise due to the growing elderly population. The study shows that stroke‑related costs are expected to decline in the under‑55 population, while the 55+ age group will see significant cost increases.
The marked rise in ischemic stroke: Unlike hemorrhagic stroke, the incidence of ischemic stroke continues to climb. This is not only linked to the prevalence of underlying conditions such as hypertension and diabetes but also closely associated with lifestyle factors—dyslipidemia, physical inactivity, and others—that come with modern living. The study projects that by 2050, total stroke‑related costs for men will be 1.3 times those for women, which is related to higher exposure to risk factors such as smoking and hypertension among men.
IV. What Can We Do?
Faced with this sobering projection, we are not helpless. The study’s conclusions point clearly in one direction: strengthen primary prevention—this is the most cost‑effective strategy.
Controlling blood pressure, blood glucose, and blood lipids; quitting smoking and limiting alcohol; maintaining a healthy weight and engaging in regular physical activity—these measures can reduce the occurrence of stroke at its source. National‑level initiatives such as the “Million Disability Reduction Project” and community‑based screening programs are built on this very principle.
References:
[1] Nanjing Medical University, Shandong University, et al. Projections of stroke incidence and costs in China, 2022–2050. Stroke. 2026.